BOSTON, September 16, 2020 / PRNewswire / – Amwell®, a national leader in telehealth, today announced the price of its initial public offering of 41,222,222 Class A common shares at an initial public offering price of $ 18.00 per share for total gross proceeds of approximately $ 742 million, before deducting any sales discounts and commissions and offering fees payable by Amwell. In addition, the underwriters were granted a 30-day option to purchase up to 6,183,333 additional shares of Class A common stock at the price of the initial public offering, less any rebates and subscription fees, d. Amwell and certain shareholders of Amwell (the “”). Amwell will not receive any proceeds from the sale of Class A common shares by the selling shareholders.
The shares are expected to begin trading on the New York Stock Exchange under the symbol “AMWL” on September 17, 2020, and the offer should close on September 21, 2020, subject to customary closing conditions.
Morgan Stanley, Goldman Sachs & Co. LLC and Piper sandler act as assistant bookkeeping lead for the offering. UBS Investment Bank, Credit Suisse, Cowen and Berenberg act as bookkeepers for the offer.
A registration statement relating to the securities sold under the offer was declared effective on September 16, 2020 by the United States Securities and Exchange Commission (the “SEC”). The offer is made only by means of a prospectus. Where available, copies of the final prospectus relating to the offering may be obtained free of charge from Morgan Stanley & Co. LLC, attention Prospectus, 180 Varick Street, 2nd Floor, New York, New York 10014 or by e-mail at [email protected]; Goldman Sachs & Co. LLC, Attn: Prospectus, 200 West Street, New York, New York 10282, by phone at (866) 471-2526 or by e-mail at [email protected]; or Piper sandler & Co., Attn: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402, by phone at (800) 747-3924 or by e-mail at [email protected].
This press release does not constitute an offer to sell or the solicitation of an offer to buy such securities, nor any sale of such securities in any state or jurisdiction where such an offer, solicitation or sale would be illegal prior to the registration or qualification under the securities laws of those states or jurisdictions.
Amwell is a leading telehealth platform in United States and globally, connecting and enabling providers, insurers, patients and innovators to provide better access to more affordable and better care. Amwell believes digital healthcare delivery will transform healthcare. The company offers a single, comprehensive platform to meet all telehealth needs, from urgent care to acute and post-acute care, as well as chronic care management and healthy living. With over a decade of experience, Amwell powers telehealth solutions for over 2,000 hospitals and 55 health plan partners with over 36,000 employers, spanning over 80 million lives.
American Well and Amwell are either registered trademarks or trademarks of American Well Corporation in United States and other countries. All other trademarks used in this document are the property of their respective owners.
781-888-8219 / [email protected]